Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy
Aβ immunotherapy for Alzheimer's disease (AD) results in the removal of Av plaques and increased cerebral amyloid angiopathy (CAA). In current clinical trials, amyloid-related imaging abnormalities (ARIAs), putatively due to exacerbation of CAA, are concerning side effects. We aimed to assess t...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2014-12-01.
|
| Subjects: | |
| Online Access: | Get fulltext |